AspECT: A Phase III, Randomised, study of Aspirin and Esomeprazole Chemoprevention in Barrett’s Metaplasia
Primary Publication : The Lancet 4;392 August 2018
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
AspECT: A Phase III, Randomised, study of Aspirin and Esomeprazole Chemoprevention in Barrett’s Metaplasia
Primary Publication : The Lancet 4;392 August 2018
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial